AFG
BMY icon

Albion Financial Group’s Bristol-Myers Squibb BMY Stock Holding History

Albion Financial Group’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$46.1K Hold
800
– – ﹤0.01% 287
2026
Q1 		$48.5K Hold
800
– – ﹤0.01% 273
2025
Q4 		$43.2K Hold
800
– – ﹤0.01% 265
2025
Q3 		$36.1K Hold
800
– – ﹤0.01% 284
2025
Q2 		$37K Hold
800
– – ﹤0.01% 259
2025
Q1 		$48.8K Sell
800
-1,049
-57% -$61.1K ﹤0.01% 244
2024
Q4 		$105K Buy
1,849
+649
+54% +$36.3K 0.01% 204
2024
Q3 		$62.1K Hold
1,200
– – ﹤0.01% 235
2024
Q2 		$49.8K Sell
1,200
-785
-40% -$35.1K ﹤0.01% 241
2024
Q1 		$108K Buy
1,985
+744
+60% +$37.9K 0.01% 194
2023
Q4 		$63.7K Buy
1,241
+41
+3% +$2.15K 0.01% 217
2023
Q3 		$69.6K Hold
1,200
– – 0.01% 201
2023
Q2 		$76.7K Hold
1,200
– – 0.01% 210
2023
Q1 		$83.2K Hold
1,200
– – 0.01% 190
2022
Q4 		$86.3K Sell
1,200
-245
-17% -$18.5K 0.01% 190
2022
Q3 		$103K Sell
1,445
-404
-22% -$29.3K 0.01% 184
2022
Q2 		$142K Buy
1,849
+1
+0.1% +$76 0.01% 183
2022
Q1 		$135K Buy
1,848
+1
+0.1% +$67 0.01% 214
2021
Q4 		$115K Sell
1,847
-399
-18% -$23.4K 0.01% 238
2021
Q3 		$133K Hold
2,246
– – 0.01% 197
2021
Q2 		$150K Buy
+2,246
New +$146K 0.01% 196
2020
Q4 		$139K Buy
+2,244
New +$138K 0.01% 197
2018
Q4 		– Sell
-48,476
Closed -$3.01M – 197
2018
Q3 		$3.01M Sell
48,476
-3,033
-6% -$180K 0.41% 54
2018
Q2 		$2.85M Buy
51,509
+235
+0.5% +$12.7K 0.41% 55
2018
Q1 		$3.24M Sell
51,274
-229
-0.4% -$14.7K 0.5% 46
2017
Q4 		$3.16M Sell
51,503
-289
-0.6% -$18.1K 0.48% 47
2017
Q3 		$3.3M Buy
51,792
+27,960
+117% +$1.63M 0.5% 44
2017
Q2 		$1.33M Sell
23,832
-616
-3% -$33.5K 0.22% 72
2017
Q1 		$1.33M Buy
24,448
+4,370
+22% +$240K 0.2% 72
2016
Q4 		$1.17M Buy
20,078
+3,434
+21% +$188K 0.19% 76
2016
Q3 		$897K Buy
16,644
+9,300
+127% +$597K 0.15% 95
2016
Q2 		$540K Buy
7,344
+1,800
+32% +$127K 0.1% 108
2016
Q1 		$354K Buy
5,544
+1
+0% +$63 0.06% 131
2015
Q4 		$381K Hold
5,543
– – 0.07% 130
2015
Q3 		$328K Sell
5,543
-54
-1% -$3.43K 0.06% 135
2015
Q2 		$372K Buy
5,597
+83
+2% +$5.47K 0.06% 135
2015
Q1 		$356K Sell
5,514
-499
-8% -$31.2K 0.06% 132
2014
Q4 		$355K Buy
6,013
+1
+0% +$56 0.06% 134
2014
Q3 		$308K Hold
6,012
– – 0.05% 141
2014
Q2 		$292K Buy
6,012
+1
+0% +$49 0.05% 153
2014
Q1 		$312K Sell
6,011
-500
-8% -$26.6K 0.06% 147
2013
Q4 		$346K Buy
6,511
+1
+0% +$51 0.06% 128
2013
Q3 		$301K Buy
6,510
+1
+0% +$44 0.06% 129
2013
Q2 		$291K Buy
+6,509
New +$283K 0.06% 119

Other funds holding BMY

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Albion Financial Group's BMY Position: Q2 2026 in Review

Albion Financial Group held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 800 shares worth $46.1K. The position accounts for ﹤0.01% of the portfolio, ranked #287.

Albion Financial Group first reported a position in BMY in Q2 2013 and has held it in 44 quarters since. The position peaked at $3.3M in Q3 2017. 796 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Albion Financial Group held 800 shares of Bristol-Myers Squibb worth $46.1K as of Q2 2026.
  • Albion Financial Group left its Bristol-Myers Squibb share count unchanged in Q2 2026.
  • Bristol-Myers Squibb made up ﹤0.01% of Albion Financial Group's portfolio in Q2 2026, its #287 holding.
  • Albion Financial Group first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 44 quarters since.
  • Albion Financial Group's Bristol-Myers Squibb position peaked at $3.3M in Q3 2017.
  • 796 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Albion Financial Group's 13F filing for Q2 2026, filed 22 Jul 2026.